Optimizing Translation: In-Country Review in Life Sciences
Part 2: Streamlining the ICR Process
In an ideal world, medical device and pharmaceutical organizations could eliminate in-country review (ICR) from their translation process. However, many life sciences companies will likely maintain their ICR process due to quality and regulatory policies.
In this guide, we take a look at the solutions you can put in place to make the ICR process as streamlined and resource-efficient as possible.
Get your copy today to learn about...
The role of outsourcing in streamlining ICR
How to create a suitable process & review environment
